WO2001075104A1 - Nouvelle proteine, adn codant pour celle-ci, et son procede de production - Google Patents

Nouvelle proteine, adn codant pour celle-ci, et son procede de production Download PDF

Info

Publication number
WO2001075104A1
WO2001075104A1 PCT/JP2001/002615 JP0102615W WO0175104A1 WO 2001075104 A1 WO2001075104 A1 WO 2001075104A1 JP 0102615 W JP0102615 W JP 0102615W WO 0175104 A1 WO0175104 A1 WO 0175104A1
Authority
WO
WIPO (PCT)
Prior art keywords
same
dna
producing
novel protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2001/002615
Other languages
English (en)
French (fr)
Inventor
Tetsuya Ohtaki
Yasushi Shintani
Yasuko Terao
Satoshi Kumano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to CA002404257A priority Critical patent/CA2404257A1/en
Priority to EP01917583A priority patent/EP1273658A4/en
Priority to US10/240,224 priority patent/US20050240008A1/en
Priority to AU2001244609A priority patent/AU2001244609A1/en
Publication of WO2001075104A1 publication Critical patent/WO2001075104A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/JP2001/002615 2000-03-30 2001-03-29 Nouvelle proteine, adn codant pour celle-ci, et son procede de production Ceased WO2001075104A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002404257A CA2404257A1 (en) 2000-03-30 2001-03-29 Novel protein, dna thereof and process for producing the same
EP01917583A EP1273658A4 (en) 2000-03-30 2001-03-29 NEW PROTEIN, THEIR DNA AND METHOD FOR THE PRODUCTION THEREOF
US10/240,224 US20050240008A1 (en) 2000-03-30 2001-03-29 Novel protein, dna thereof and process for producing the same
AU2001244609A AU2001244609A1 (en) 2000-03-30 2001-03-29 Novel protein, dna thereof and process for producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000093575 2000-03-30
JP2000-093575 2000-03-30

Publications (1)

Publication Number Publication Date
WO2001075104A1 true WO2001075104A1 (fr) 2001-10-11

Family

ID=18608742

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/002615 Ceased WO2001075104A1 (fr) 2000-03-30 2001-03-29 Nouvelle proteine, adn codant pour celle-ci, et son procede de production

Country Status (5)

Country Link
US (1) US20050240008A1 (ja)
EP (1) EP1273658A4 (ja)
AU (1) AU2001244609A1 (ja)
CA (1) CA2404257A1 (ja)
WO (1) WO2001075104A1 (ja)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072816A1 (fr) * 2001-02-26 2002-09-19 Takeda Chemical Industries, Ltd. Proteine de recepteur murin de type kiss-1 et adn correspondant
WO2003060125A1 (fr) * 2002-01-11 2003-07-24 Takeda Chemical Industries, Ltd. Procede de production du peptide kiss-1
WO2002059344A3 (en) * 2000-12-18 2003-08-14 Merck & Co Inc Gpr54 g protein-coupled receptor
WO2004006934A3 (de) * 2002-07-10 2004-04-01 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecane als modulatoren des guanin-nukleotid bindenden roteins zur behandlung von tumoren
WO2004063221A1 (ja) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited メタスチン誘導体およびその用途
WO2004080479A1 (ja) * 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤
US6800611B2 (en) 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
WO2008017372A1 (en) 2006-08-09 2008-02-14 Maria Vincenza Carriero Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
WO2009131191A1 (ja) 2008-04-24 2009-10-29 武田薬品工業株式会社 メタスチン誘導体およびその用途
EP2113513A2 (en) 2004-06-25 2009-11-04 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
WO2010013762A1 (ja) 2008-07-30 2010-02-04 武田薬品工業株式会社 メタスチン誘導体およびその用途
US7691979B2 (en) * 2001-09-19 2010-04-06 Takeda Pharmaceutical Company Limited Anti-metastin antibody and its use
US7786083B2 (en) 2006-10-25 2010-08-31 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US7960348B2 (en) 2005-12-22 2011-06-14 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US9682153B2 (en) 2008-09-19 2017-06-20 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US11427615B2 (en) 2017-07-05 2022-08-30 Xdcexplorer (Shanghai) Co., Ltd. Peptide compound and application thereof, and composition containing peptide compound

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304021D0 (en) * 2003-02-21 2003-03-26 Pfizer Ltd Treatment of hypertension
US20090099334A1 (en) * 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
GB0719592D0 (en) 2007-10-08 2007-11-14 Medical Res Council Compound, use and method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003548A1 (en) * 1996-07-19 1998-01-29 Astra Pharma Inc. A novel galanin receptor
WO2000024890A1 (en) * 1998-10-27 2000-05-04 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
WO2000050563A2 (en) * 1999-02-24 2000-08-31 Merck & Co., Inc. G protein-coupled receptor resembling galanin receptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003548A1 (en) * 1996-07-19 1998-01-29 Astra Pharma Inc. A novel galanin receptor
WO2000024890A1 (en) * 1998-10-27 2000-05-04 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
WO2000050563A2 (en) * 1999-02-24 2000-08-31 Merck & Co., Inc. G protein-coupled receptor resembling galanin receptors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANDE WEST ET AL.: "Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1)", GENOMICS, vol. 54, 1998, pages 145 - 148, XP002942230 *
MARIA DE FATIMA BONALDO ET AL.: "Normalization and subtraction: two approaches to facilitate gene discovery", GENOME RES., vol. 6, no. 9, 1996, pages 791 - 806, XP002942229 *
See also references of EP1273658A4 *
TETSUYA OHTAKI ET AL.: "Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor", NATURE, vol. 411, May 2001 (2001-05-01), pages 613 - 617, XP002942231 *

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059344A3 (en) * 2000-12-18 2003-08-14 Merck & Co Inc Gpr54 g protein-coupled receptor
EP1363655A4 (en) * 2000-12-18 2005-04-06 Merck & Co Inc FOR A G-PROTEIN-COUPLED RECEPTOR - GPR 54 - FROM HUMAN AND MOUSE-CODING, ISOLATED NUCLEIC ACID MOLECULES, PROTEINS CODED THEREBY, TRANSFORMED CELLS THEREOF, AND USES THEREOF
WO2002072816A1 (fr) * 2001-02-26 2002-09-19 Takeda Chemical Industries, Ltd. Proteine de recepteur murin de type kiss-1 et adn correspondant
US7691979B2 (en) * 2001-09-19 2010-04-06 Takeda Pharmaceutical Company Limited Anti-metastin antibody and its use
WO2003060125A1 (fr) * 2002-01-11 2003-07-24 Takeda Chemical Industries, Ltd. Procede de production du peptide kiss-1
WO2004006934A3 (de) * 2002-07-10 2004-04-01 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecane als modulatoren des guanin-nukleotid bindenden roteins zur behandlung von tumoren
WO2004063221A1 (ja) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited メタスチン誘導体およびその用途
US8361968B2 (en) 2002-12-26 2013-01-29 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US6800611B2 (en) 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
US7754220B2 (en) 2003-03-12 2010-07-13 Takeda Pharmaceutical Company Limited Methods of inhibiting secretion of follicle-stimulating hormone and testosterone
WO2004080479A1 (ja) * 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤
EP2113513A2 (en) 2004-06-25 2009-11-04 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US7625869B2 (en) 2004-06-25 2009-12-01 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8778871B2 (en) 2004-06-25 2014-07-15 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US7960348B2 (en) 2005-12-22 2011-06-14 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
EP2213680A1 (en) 2006-08-09 2010-08-04 Maria Vincenza Carriero Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
EP2230245A1 (en) 2006-08-09 2010-09-22 Maria Vincenza Carriero Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
WO2008017372A1 (en) 2006-08-09 2008-02-14 Maria Vincenza Carriero Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
US8765909B2 (en) 2006-10-25 2014-07-01 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US7786083B2 (en) 2006-10-25 2010-08-31 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
WO2009131191A1 (ja) 2008-04-24 2009-10-29 武田薬品工業株式会社 メタスチン誘導体およびその用途
WO2010013762A1 (ja) 2008-07-30 2010-02-04 武田薬品工業株式会社 メタスチン誘導体およびその用途
EP3210998A1 (en) 2008-07-30 2017-08-30 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
US9682153B2 (en) 2008-09-19 2017-06-20 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US11427615B2 (en) 2017-07-05 2022-08-30 Xdcexplorer (Shanghai) Co., Ltd. Peptide compound and application thereof, and composition containing peptide compound
US11807660B2 (en) 2017-07-05 2023-11-07 Xdcexplorer (Shanghai) Co., Ltd. Peptide compound and application thereof, and composition containing peptide compound
US11981753B2 (en) 2017-07-05 2024-05-14 Shangpharma Innovation Inc. Peptide compound and application thereof, and composition containing peptide compound

Also Published As

Publication number Publication date
EP1273658A4 (en) 2004-08-11
CA2404257A1 (en) 2001-10-11
AU2001244609A1 (en) 2001-10-15
US20050240008A1 (en) 2005-10-27
EP1273658A1 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
WO2001075104A1 (fr) Nouvelle proteine, adn codant pour celle-ci, et son procede de production
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AU2002338494A1 (en) Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
HRP20000053B1 (en) Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
MXPA03008419A (es) Amidas de acido antranilico, metodo para su produccion, su uso como agentes anti-arritmia, y preparaciones farmaceuticas de las mismas.
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
HUP0001945A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical copositions containing them
HUP0102921A3 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
HUP0203060A3 (en) Sustained release complex of a peptide, process for its preparation and pharmaceutical composition containing the same
PL354322A1 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
AU6920798A (en) Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
ZA965712B (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
WO2004073033A3 (en) Material incapsulation system
AU7961200A (en) Urea derivative, process for producing the same, and medicine containing the urea derivative
ZA988711B (en) New tetracycles, process for their production and pharmaceutical preparations containing these compounds.
HUP0100054A3 (en) Pyrimidinyloxi carboxylic acid derivatives, carrying amido side-chains, process for producing them, their use and medicaments containing the same
AU2001258200A1 (en) Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2001284477A1 (en) Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy -4(S)-(N-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
WO2001021140A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
AU1525301A (en) Process for preparing improved protein hydrolysates
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
WO2002029053A1 (fr) Nouvelle proteine de recepteur couple a la proteine g et adn correspondant
AU2003300694A1 (en) Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001917583

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2404257

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10240224

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001917583

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001917583

Country of ref document: EP